Mortality rate in COVID-19 positive patients with acute kidney injury requiring hemodialysis.
DOI:
https://doi.org/10.29309/TPMJ/2022.29.04.6849Keywords:
Acute Kidney Injury, Covid-19 Positive P, Hemodialysis, Mortality RateAbstract
Objective: To determine the mortality rate in COVID-19 positive patients with acute kidney injury requiring hemodialysis. Study Design: Observational Retrospective study. Setting: Department of Nephrology, Patel Hospital, Karachi. Period: March, 2020 to May 2021. Material & Methods: Data was collected retrospectively from medical records of patients. Patients with positive COVID-19 PCR and having AKI requiring hemodialysis were included in the study. Data was collected by complete evaluation of COVID-19 patient records and their symptoms, clinical status and final outcome during their hospital stay was noted. Results: The frequency of acute kidney injury requiring hemodialysis in our tertiary care setup was found to be 12.2% (n=41). Amongst these there were 53.7% males (n=22) and 46.3% females (n=19) and the mean age of patients was found to be 64.82+ 11.2 years. The mean level of lymphocyte count was found to be 11.3 + 4.8 *109/L. The in hospital mortality of COVID-19 positive patients having AKI was documented to be 73.2% (n=30) as shown in Table-IV. The other group of patients included 11 patients who recovered from acute kidney injury after hemodialysis sessions and were discharged from the hospital. Conclusion: Since COVID-19 infection became pandemic in 2020 there still needs to be a lot of research done in different populations. Hospitalized patients with COVID-19 infection should be Screen for kidney impairment and provided proper treatment. There has been found a very close association between the severity of acute kidney injury and mortality among the critically ill patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 The Professional Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.